$VXRT Vaxart, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Vaxart, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Vaxart, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Vaxart, Inc. for free.
IRS Number: 591212264
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: VXRT
Company Address: 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO 94080
Former name: NORTH AMERICAN BIOLOGICALS INC, date of change: 1992-07-03
Former name: NABI /DE/, date of change: 1996-04-05
Former name: NABI BIOPHARMACEUTICALS, date of change: 2002-03-04
Former name: Biota Pharmaceuticals, Inc., date of change: 2012-11-13
Former name: Aviragen Therapeutics, Inc., date of change: 2016-04-13
Market Capitalization: $43.28M
Prev close: $1.14
Average Daily Volume: 80,550
Days Low: $1.08
Year Low: $0.93
Year High: $2.00
Vaxart, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17 2021 | VXRT | Vaxart, Inc. | Yedid Robert A. | Director | Option Exercise | A | 7.79 | 15,097 | 117,606 | 15,097 | |
| Jun 17 2021 | VXRT | Vaxart, Inc. | Finney Michael J. | Director | Option Exercise | A | 7.79 | 15,097 | 117,606 | 15,097 | |
| Jun 17 2021 | VXRT | Vaxart, Inc. | Echerd Margaret | SVP, Principal Accn ... | Option Exercise | A | 6.27 | 100,000 | 627,000 | 100,000 | |
| May 10 2021 | VXRT | Vaxart, Inc. | Latour Wouter | Director | Option Exercise | M | 1.70 | 100,000 | 170,000 | 700,000 | |
| May 10 2021 | VXRT | Vaxart, Inc. | Latour Wouter | Director | Option Exercise | M | 1.70 | 100,000 | 170,000 | 800,000 | |
| May 10 2021 | VXRT | Vaxart, Inc. | Latour Wouter | Director | Sell | S | 7.13 | 100,000 | 712,750 | 0 | 100 K to 0 (-100.00 %) |
| May 10 2021 | VXRT | Vaxart, Inc. | Latour Wouter | Director | Buy | M | 1.70 | 100,000 | 170,000 | 100,000 | 0 to 100 K |
| May 10 2021 | VXRT | Vaxart, Inc. | Latour Wouter | Director | Sell | S | 6.54 | 100,000 | 653,890 | 0 | 100 K to 0 (-100.00 %) |
| May 10 2021 | VXRT | Vaxart, Inc. | Latour Wouter | Director | Buy | M | 1.70 | 100,000 | 170,000 | 100,000 | 0 to 100 K |
| Mar 18 2021 | VXRT | Vaxart, Inc. | Tucker Sean | Chief Scientific Of ... | Option Exercise | M | 6.49 | 1,006 | 6,529 | 0 | |
| Mar 18 2021 | VXRT | Vaxart, Inc. | Tucker Sean | Chief Scientific Of ... | Buy | M | 6.49 | 1,006 | 6,529 | 48,053 | 47 K to 48.1 K (+2.14 %) |
| Mar 05 2021 | VXRT | Vaxart, Inc. | Latour Wouter | Director | Option Exercise | M | 0.77 | 150,000 | 115,500 | 213,261 | |
| Mar 05 2021 | VXRT | Vaxart, Inc. | Latour Wouter | Director | Sell | S | 6.04 | 150,000 | 906,450 | 0 | 150 K to 0 (-100.00 %) |
| Mar 05 2021 | VXRT | Vaxart, Inc. | Latour Wouter | Director | Buy | M | 0.77 | 150,000 | 115,500 | 150,000 | 0 to 150 K |
| Nov 23 2020 | VXRT | Vaxart, Inc. | Latour Wouter | Director | Sell | S | 6.32 | 333,334 | 2,108,138 | 0 | 333.3 K to 0 (-100.00 %) |